Acute pancreatitis in children with acute lymphoblastic leukemia correlates with L-asparaginase dose intensity

Chen, Chi-BoChi-BoChenHSIU-HAO CHANGSHU-WEI CHOUYUNG-LI YANGMENG-YAO LUSHIANN-TANG JOUHUEY-LING CHENYEN-HSUAN NILin, Dong-TsamnDong-TsamnLinChang, Mei-HweiMei-HweiChangJIA-FENG WU2022-03-282022-03-282021-10-300031-3998https://scholars.lib.ntu.edu.tw/handle/123456789/602280L-Asparaginase (L-Asp) is an important therapeutic for childhood acute lymphoblastic leukemia (ALL). Asparaginase-associated pancreatitis (AAP) is a severe complication of L-Asp related to the dosage. We investigated the incidence of, and risk factors for, AAP in pediatric patients with ALL.enCOLI; PHARMACOKINETICS; TOXICITY; ADULTSAcute pancreatitis in children with acute lymphoblastic leukemia correlates with L-asparaginase dose intensityjournal article10.1038/s41390-021-01796-w347183532-s2.0-85118452077WOS:000712939100005https://scholars.lib.ntu.edu.tw/handle/123456789/594259